Drugs.com - Pharma Industry News

Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian Cancer

MONDAY, May 12, 2025 -- The addition of bevacizumab to first-line (1L) chemotherapy offers real-world benefit to patients with epithelial ovarian cancer with high-risk prognostic factors, according to a study published online May 12 in...

May 12, 2025 - 18:23
 0
Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian Cancer
MONDAY, May 12, 2025 -- The addition of bevacizumab to first-line (1L) chemotherapy offers real-world benefit to patients with epithelial ovarian cancer with high-risk prognostic factors, according to a study published online May 12 in...
Read More

Tags:

Previous Article

Fierce Biotech Layoff Tracker 2025: 10x Genomics cuts 8% of global workforce; NG...

Next Article

BCG Revaccination Does Not Provide Protection From Sustained Mycobacterium Tuber...

Related Posts

Female Ophthalmology Trainees Perform Fewer Cataract Procedures During Residency

Female Ophthalmology Trainees Perform Fewer Cataract Pr...

May 8, 2025  0

Racial Disparities Persist in Immediate Breast Reconstruction Rates

Racial Disparities Persist in Immediate Breast Reconstr...

May 7, 2025  0

Hyperglycemia, Insulin Resistance in Teens Linked to Worsening Cardiac Damage at Age 24

Hyperglycemia, Insulin Resistance in Teens Linked to Wo...

May 9, 2025  0